AFP and hepatocellular carcinoma: Analysis of sera from AFP-negative and AFP-positive HCC patients demonstrated that serum IL-41 level was positively correlated with ALT and AST levels in AFP-positive HCC patients (Figures 1D–F, Supplementary Figures S1D, E) but not in AFP-negative HCC patients.